tiprankstipranks
Trending News
More News >
Shalby Ltd. (IN:SHALBY)
:SHALBY
India Market
Advertisement

Shalby Ltd. (SHALBY) Price & Analysis

Compare
0 Followers

SHALBY Stock Chart & Stats

₹247.10
-₹4.08(-1.73%)
At close: 4:00 PM EST
₹247.10
-₹4.08(-1.73%)

SHALBY FAQ

What was Shalby Ltd.’s price range in the past 12 months?
Shalby Ltd. lowest stock price was ₹177.20 and its highest was ₹274.50 in the past 12 months.
    What is Shalby Ltd.’s market cap?
    Shalby Ltd.’s market cap is ₹26.62B.
      When is Shalby Ltd.’s upcoming earnings report date?
      Shalby Ltd.’s upcoming earnings report date is Feb 09, 2026 which is in 108 days.
        How were Shalby Ltd.’s earnings last quarter?
        Currently, no data Available
        Is Shalby Ltd. overvalued?
        According to Wall Street analysts Shalby Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Shalby Ltd. pay dividends?
          Shalby Ltd. pays a Annually dividend of ₹1.2 which represents an annual dividend yield of 0.48%. See more information on Shalby Ltd. dividends here
            What is Shalby Ltd.’s EPS estimate?
            Shalby Ltd.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Shalby Ltd. have?
            Shalby Ltd. has 108,009,766 shares outstanding.
              What happened to Shalby Ltd.’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of Shalby Ltd.?
              Currently, no hedge funds are holding shares in IN:SHALBY

              Company Description

              Shalby Ltd.

              Shalby Limited operates multi-specialty hospitals primarily in India. The company offers arthroscopy, arthroplasty, cardiology, cardiothoracic and vascular surgery, cosmetic and aesthetic, dental cosmetic and implant ology, emergency medicine, endocrinology, endoscopy and laparoscopy, ENT surgery, gastroentero surgery, gastroenterology, general medicine and surgery, hair transplant, liver disease and transplant, and hip and knee joint replacement services. It also provides infectious disease, infertility and IVF, intensive and critical care, maxillofacial surgery, nephrology, neuro surgery, neurology, obesity surgery, obstetrics and gynecology, oncology, oncosurgery, ophthalmology and glaucoma, orthopedic and trauma, pediatric orthopedic, pathology and microbiology, pediatrics and neonatology, plastic surgery, pulmonology and chest, radiology and imaging, rheumatology, trauma, organ donation, and urosurgery services. The company operates 11 hospitals comprising aggregate capacity of 2,012 beds. In addition, it offers outpatient services through 50 outpatient clinics, as well as provides educational programs and fellowships for paramedical students and other healthcare professionals; and homecare health services, such as attendants, doctors, nursing, physiotherapy, pathology, pharmacy, and medical equipment, as well as conducts clinical research trials. It also operates in Kenya, Tanzania, Rwanda, Uganda, the United Arab Emirates, Bangladesh, Cambodia, Jakarta, Oman, Uzbekistan, Nepal, and internationally. The company was formerly known as Shalby Hospitals Limited and changed its name to Shalby Limited in February 2008. Shalby Limited was founded in 1994 and is headquartered in Ahmedabad, India.

              Shalby Ltd. (SHALBY) Earnings & Revenues

              Similar Stocks
              Company
              Price & Change
              Follow
              Krsnaa Diagnostics Limited
              Panacea Biotec Limited
              SMS Pharmaceuticals Limited
              TTK Healthcare Limited
              Vimta Labs Limited
              Popular Stocks
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis